| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $30.5M | — | -8.2% |
| Cost of Revenue | $22.3M | — | -8.1% |
| Gross Profit | $8.2M | — | -8.3% |
| R&D Expense | $283K | — | -10.8% |
| SG&A Expense | $2.4M | — | -12.8% |
| Operating Income | -$691K | — | +46.0% |
| Pre-tax Income | -$1.1M | — | +28.1% |
| Income Tax | $25K | — | +103.3% |
| Net Income | -$969K | — | -54.1% |
| EPS (Basic) | -$0.50 | — | -614.3% |
| EPS (Diluted) | -$0.50 | — | -614.3% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $2.7M | +42.1% | +125.0% |
| Accounts Receivable | $13.6M | -1.5% | -27.9% |
| Inventory | $14.2M | -7.0% | +13.4% |
| Current Assets | $50.9M | -1.2% | +9.5% |
| Total Assets | $68.2M | -2.0% | -0.5% |
| Current Liabilities | $44.3M | +0.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$326K | — | +80.3% |
| Capital Expenditures | $80K | — | -77.2% |
| Investing Cash Flow | -$80K | — | +82.3% |
| Financing Cash Flow | $1.3M | — | +195.8% |
| Free Cash Flow | -$405K | — | +79.7% |
| +18.9% |
| Total Liabilities | $53.8M | -0.2% | +13.2% |
| Stockholders' Equity | $16.2M | -6.5% | -25.8% |